|
Alembic Pharma receives USFDA approval for Efinaconazole Topical Solution, 10%> |
|
Alembic Pharma gets USFDA nod for antifungal ANDA> |
|
Alembic Pharma slumps after receiving two USFDA observations for karakhadi facility> |
|
Alembic Pharmaceuticals receives USFDA approval for Carbidopa, Levodopa and Entacapone Tablets> |
|
Alembic Pharma receives USFDA approval for Parkinson’s drug tablets> |
|
Alembic Pharmaceuticals consolidated net profit declines 3.94% in the December 2025 quarter> |
|
Alembic Pharmaceuticals receives USFDA approval for Durezol Ophthalmic Emulsion, 0.05%> |
|
Alembic Pharmaceuticals to declare Quarterly Results> |
|
Alembic Pharmaceuticals receives USFDA tentative approval for Bosutinib Tablets, 400 mg> |
|
Alembic Pharma receives USFDA tentative approval for Bosutinib Tablets> |